5-amino-1mq and cd38 inhibitor synergy nad+ Dysregulation of Niacin-Derived Salvage Pathway Markers (CD38, NAMPT, SIRT1) Across Albuminuria Stages in Type 2 Diabetes Targeting CD38-dependent NAD+ metabolism to
Targeting CD38 dependent NAD+ metabolism to mitigate multiple organ fibrosis ScienceDirect Biological Functions and Therapeutic Potential of NAD+ Metabolism in Gynecological Cancers Rapid Discovery of CD38 Inhibitor via DNA Encoded Natural Product Library Screening Dual targeting of SLC25A51 and succinate dehydrogenase selectively depletes mitochondrial NAD+ to eradicate KRAS driven AML: Cell Metabolism
Pay in 4 interest-free payments of $6.64 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7



